CareDx Inc (CDNA):企業の財務・戦略的SWOT分析

◆英語タイトル:CareDx Inc (CDNA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH26721FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and identify acute cellular rejection in heart transplant recipients; AlloSure, a non-invasive blood test that measures donor-derived cell-free DNA (dd-cfDNA), an indicator of kidney injury. CareDx also provides laboratory products along the pre- and post-transplant testing continuum including human leukocyte antigen (HLA) typing kits and testing solutions. The company offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc Key Recent Developments

Apr 08,2021: CareDx announces new HLA typing service offering for research purposes
Apr 05,2021: CareDx to participate in National Kidney Foundation 2021 Spring Clinical Meetings
Mar 31,2021: CareDx Enhances Leadership Team with Key Appointments
Mar 11,2021: CareDx Names Ankur Dhingra as New Chief Financial Officer

This comprehensive SWOT profile of CareDx Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CareDx Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

CareDx Inc – Key Information
CareDx Inc – Overview
CareDx Inc – Key Employees
CareDx Inc – Key Employee Biographies
CareDx Inc – Key Operational Heads
CareDx Inc – Major Products and Services
CareDx Inc – History
CareDx Inc – Company Statement
CareDx Inc – Locations And Subsidiaries
CareDx Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

CareDx Inc – Business Description
CareDx Inc – Corporate Strategy
CareDx Inc – SWOT Analysis
SWOT Analysis – Overview
CareDx Inc – Strengths
CareDx Inc – Weaknesses
CareDx Inc – Opportunities
CareDx Inc – Threats
CareDx Inc – Key Competitors

Section 3 – Company Financial Performance Charts

CareDx Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

CareDx Inc, Key Information
CareDx Inc, Key Ratios
CareDx Inc, Share Data
CareDx Inc, Major Products and Services
CareDx Inc, History
CareDx Inc, Key Employees
CareDx Inc, Key Employee Biographies
CareDx Inc, Key Operational Heads
CareDx Inc, Other Locations
CareDx Inc, Subsidiaries
CareDx Inc, Key Competitors
CareDx Inc, SWOT Analysis
CareDx Inc, Ratios based on current share price
CareDx Inc, Annual Ratios
CareDx Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[CareDx Inc (CDNA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncolytics Biotech Inc (ONC)-医療機器分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Mckesson Europe AG (CLS1):企業の財務・戦略的SWOT分析
    Mckesson Europe AG (CLS1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Inter Pipeline Ltd (IPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Inter Pipeline Ltd (Inter Pipeline) is an integrated energy infrastructure business. The company is involved in petroleum transportation, natural gas liquids (NGLs) processing and storage of bulk liquids. Its energy infrastructure comprises pipeline systems, storage terminals, straddle and o …
  • Integra LifeSciences Holdings Corp (IART)-医療機器分野:企業M&A・提携分析
    Summary Integra LifeSciences Holdings Corp (Integra) is a medical technology company. Integra’s orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The company’s neurosu …
  • Electricity Authority of Cyprus:企業の戦略的SWOT分析
    Electricity Authority of Cyprus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Medpace Inc (MEDP)-製薬・医療分野:企業M&A・提携分析
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization's services comprise medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial management, …
  • Denny’s Corporation:戦略・SWOT・企業財務分析
    Denny's Corporation - Strategy, SWOT and Corporate Finance Report Summary Denny's Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Premaitha Health Plc (NIPT):医療機器:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • CJ Foodville Corporation:企業の戦略・SWOT・財務分析
    CJ Foodville Corporation - Strategy, SWOT and Corporate Finance Report Summary CJ Foodville Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hanmi Pharmaceuticals Co Ltd (128940)-医療機器分野:企業M&A・提携分析
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Visser & Smit Hanab BV:企業の戦略的SWOT分析
    Visser & Smit Hanab BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aevi Genomic Medicine Inc (GNMX):医療機器:M&Aディール及び事業提携情報
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …
  • General Biologicals Corp (4117)-医療機器分野:企業M&A・提携分析
    Summary General Biologicals Corp (GBC) is a medical device company that develops and manufactures diagnostics and pharmaceutical products. The company provides in-vitro diagnostic devices. It offers liver inspection tools such as test reagents and equipment. GBC’s products include real-time PCR kits …
  • Currence Holding B.V.:企業の戦略・SWOT・財務情報
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dan Hotels Corporation Ltd:戦略・SWOT・企業財務分析
    Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mobidiag Ltd:企業の製品パイプライン分析
    Summary Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screeni …
  • Point Resources AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Point Resources AS (Point Resources) ,is engaged in developing, exploring and production of petroleum products. It explores and produces crude oil, gas and natural gas liquids (NGLs) through Ringhorne, Balder and Jotun fields. Point Resources also offers seismic surveys and drilling services …
  • QuickLogic Corporation (QUIK):企業の財務・戦略的SWOT分析
    QuickLogic Corporation (QUIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Eyevensys SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eyevensys SAS (Eyevensys) is a clinical stage biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its lead product, EYS-606, is a soluble TNFa receptor plasmid associated with the ETIS device to treat non-infectious intermediate and posterior uveitis(NIU); EYS- …
  • RhythmOne plc:企業のM&A・事業提携・投資動向
    RhythmOne plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RhythmOne plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆